Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial)

[1] Thongprayoon C(2016)Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study BMC Pharmacol Toxicol 17 19-124

[2] Cheungpasitporn W(1998)A double-blind, dose–response study of midodrine in neurogenic orthostatic hypotension Neurology 51 120-1051

[3] Harrison AM(1997)Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine study group JAMA 277 1046-48

[4] Carrera P(1993)Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine Am J Med 95 38-2558

[5] Srivali N(2004)Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review Nephrol Dial Transplant 19 2553-762

[6] Kittamongkolchai W(2013)Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions J Crit Care 28 756-1383

[7] Erdogan A(2014)Safety of oral midodrine as a method of weaning from intravenous vasoactive medication in the medical intensive care unit Chest 146 224A-842

[8] Kashani KB(2016)Feasibility, utility, and safety of midodrine during recovery phase from septic shock Chest 149 1380-79

[9] Wright RA(2002)Midodrine, an alternative to intravenous vasopressor therapy after spinal surgery Eur J Anaesthesiol 19 841-97

[10] Kaufmann HC(2005)Successful treatment of hypotension associated with stunned myocardium with oral midodrine therapy J Cardiovasc Pharmacol Ther 10 77-381

[1] Thongprayoon C(2016)Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study BMC Pharmacol Toxicol 17 19-124

[2] Cheungpasitporn W(1998)A double-blind, dose–response study of midodrine in neurogenic orthostatic hypotension Neurology 51 120-1051

[3] Harrison AM(1997)Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine study group JAMA 277 1046-48

[4] Carrera P(1993)Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine Am J Med 95 38-2558

[5] Srivali N(2004)Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review Nephrol Dial Transplant 19 2553-762

[6] Kittamongkolchai W(2013)Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions J Crit Care 28 756-1383

[7] Erdogan A(2014)Safety of oral midodrine as a method of weaning from intravenous vasoactive medication in the medical intensive care unit Chest 146 224A-842

[8] Kashani KB(2016)Feasibility, utility, and safety of midodrine during recovery phase from septic shock Chest 149 1380-79

[9] Wright RA(2002)Midodrine, an alternative to intravenous vasopressor therapy after spinal surgery Eur J Anaesthesiol 19 841-97

[10] Kaufmann HC(2005)Successful treatment of hypotension associated with stunned myocardium with oral midodrine therapy J Cardiovasc Pharmacol Ther 10 77-381